Promoting Organ Donor Registration in Family Physician Offices

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Unknown status
CT.gov ID
NCT03213171
Collaborator
Ottawa Hospital Research Institute (Other), Institute for Clinical Evaluative Sciences (Other), Canadian Institutes of Health Research (CIHR) (Other)
6
2
2
18.1
3
0.2

Study Details

Study Description

Brief Summary

This study evaluates the effects of using reception staff to prompt patients by providing a pamphlet and an opportunity to register in the waiting room via a mobile tablet on deceased organ donor registration rates.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Reception staff providing handout.
  • Behavioral: Mobile Tablet (e.g. iPad)
N/A

Detailed Description

Background: There is a worldwide shortage of organs available for transplant, leading to preventable morbidity and mortality. While the majority of the general public in many countries support organ donation, actual donor registration rates are substantially out of step with these views. For instance, in Canada most Canadians support organ donation but less than 25% in most provinces have registered. The family physician office is a promising yet underused setting in which to address known barriers and facilitators to registration for deceased organ and tissue donation and to provide an immediate opportunity to register while in the waiting room for those wanting to do so.

Methods/Design: The investigators aim to evaluate the effects of having reception staff in family physician offices to prompt patients upon check-in with an educational pamphlet using a cluster, stepped-wedge randomized design. A mobile tablet will also be added to the waiting area to provide patients with the immediate opportunity to register. Family physicians are also provided with an educational booklet and encouraged to discuss organ donation with their patients. The investigators will use behaviour change techniques designed to address previously anticipated barriers and enablers to organ and tissue donation registration. The investigators will evaluate the effectiveness of the intervention conducted in six family physician offices in Ontario, Canada. Following a two-week baseline control period, offices will cross sequentially into the intervention arm in a random sequence at two-week intervals until all offices deliver the intervention (baseline + two weeks for each of six offices). The primary outcome will be the proportion of patients that have registered for deceased organ donation following in the 7 days following their office visit, using routinely collected registry data (i.e. administrative databases). The investigators will also conduct a qualitative post-trial process evaluation will assess reception staff and family physicians experiences with the intervention.

Discussion: Promoting organ and donor registration remains an important strategy for organ procurement organizations and patients worldwide. The results of this trial will inform a provincial roll-out strategy to promote organ donation in family physician offices.

Study Design

Study Type:
Interventional
Actual Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Stepped-wedge cluster randomized trialStepped-wedge cluster randomized trial
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Promoting Organ and Tissue Donation Registration in Family Physician Offices: a Pragmatic Stepped-wedge Cluster Randomized Controlled Registry Trial (RegisterNow Trial)
Actual Study Start Date :
Sep 27, 2017
Actual Primary Completion Date :
Feb 1, 2018
Anticipated Study Completion Date :
Apr 1, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual care

Usual care / Standard of care No intervention implemented

Experimental: Intervention

Reception staff providing handout; Mobile tablet that provides the immediate opportunity for patients to register in the waiting room

Behavioral: Reception staff providing handout.
Reception staff will provide an educational pamphlet to patients that have not yet registered for organ donation

Behavioral: Mobile Tablet (e.g. iPad)
Patients will have the opportunity to immediately register for organ donation using an a mobile tablet (e.g. IPad)

Outcome Measures

Primary Outcome Measures

  1. Donor registration status at 7 days [7 days]

    Donor registration status (Yes/ Not registered)

Secondary Outcome Measures

  1. Donor registration status at 14 days [14 days]

    Donor registration status (Yes/ Not registered)

  2. Donor registration status at 30 days [30 days]

    Donor registration status (Yes/ Not registered)

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 105 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion/Exclusion Criteria for Patients

Inclusion Criteria:
  • Patients that visited a family physician

  • Patients that are at least 16 years of age with a valid health card (eligibility criteria to register for organ donation in Ontario)

Inclusion/Exclusion Criteria for Family Physicians (Cluster level)

Inclusion Criteria:
  • Working at a site that sees at least 100 patients per week
Exclusion Criteria:
  • Working at multiple sites that cannot be separated in analyses

Contacts and Locations

Locations

Site City State Country Postal Code
1 City of London London Ontario Canada
2 City of Stratford Stratford Ontario Canada

Sponsors and Collaborators

  • Lawson Health Research Institute
  • Ottawa Hospital Research Institute
  • Institute for Clinical Evaluative Sciences
  • Canadian Institutes of Health Research (CIHR)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amit Garg, Professor, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT03213171
Other Study ID Numbers:
  • CIHR-SCT-151609
First Posted:
Jul 11, 2017
Last Update Posted:
Aug 15, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Amit Garg, Professor, Lawson Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2018